newsfilter
← Latest News
GlobeNewswire·

Rani Therapeutics Holdings, Inc. Announces Pricing of $3.0 Million Registered Direct Offering

SAN JOSE, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. ("Rani Therapeutics" or "Rani") (NASDAQ:RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and